A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01519791 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
880
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Pharma SA